These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8013988)

  • 1. Immunotherapy in rheumatoid arthritis: a review.
    Vitali C; Sciuto M; Bombardieri S
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():196-200. PubMed ID: 8013988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New treatments of rheumatoid arthritis for future use].
    Cantagrel A; Mazières B
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative treatment approaches for rheumatoid arthritis. T-cell regulation.
    Choy EH; Kingsley GH; Panayi GS
    Baillieres Clin Rheumatol; 1995 Nov; 9(4):653-71. PubMed ID: 8591647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomodulating therapy of rheumatoid arthritis (chronic polyarthritis): use of monoclonal antibodies].
    Horneff G; Burmester GR
    Z Rheumatol; 1995; 54(2):96-104. PubMed ID: 7540786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological treatment of rheumatoid arthritis.
    Sany J
    Clin Exp Rheumatol; 1990; 8 Suppl 5():81-8. PubMed ID: 2245532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
    VanderBorght A; Geusens P; Raus J; Stinissen P
    Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central role of T cells in rheumatoid arthritis.
    Cope AP; Schulze-Koops H; Aringer M
    Clin Exp Rheumatol; 2007; 25(5 Suppl 46):S4-11. PubMed ID: 17977483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different modes of action of high-dose immunoglobulins in rheumatoid arthritis.
    Delire M
    Acta Univ Carol Med (Praha); 1994; 40(1-4):95-9. PubMed ID: 9355681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    APMIS; 1997 Apr; 105(4):257-63. PubMed ID: 9164467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of immunosuppressive drugs on expression of surface antigens of lymphocytes in patients with rheumatoid arthritis].
    Lacki JK; Mackiewicz SH
    Pol Arch Med Wewn; 1997 Feb; 97(2):134-43. PubMed ID: 9312762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
    Chen G
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):27-36. PubMed ID: 20049648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis.
    Yocum DE
    Semin Arthritis Rheum; 1999 Aug; 29(1):27-35. PubMed ID: 10468412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
    Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
    Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of DMARD failures by means of monoclonal antibodies or biological agents.
    Kalden JR
    Clin Exp Rheumatol; 1997; 15 Suppl 17():S91-8. PubMed ID: 9266139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects in the immunological treatments of rheumatoid arthritis.
    Sany J
    Scand J Rheumatol Suppl; 1987; 66():129-36. PubMed ID: 3330296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.
    Wiendl H; Hohlfeld R
    BioDrugs; 2002; 16(3):183-200. PubMed ID: 12102646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with selected synovial T cells in rheumatoid arthritis.
    Chen G; Li N; Zang YC; Zhang D; He D; Feng G; Ni L; Xu R; Wang L; Shen B; Zhang JZ
    Arthritis Rheum; 2007 Feb; 56(2):453-63. PubMed ID: 17265481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-CD4 therapy in treatment of rheumatoid arthritis--have the die been cast?].
    Keysser G; Alpermann U; Burmester GR
    Z Rheumatol; 1998 Oct; 57(5):320-5. PubMed ID: 9864838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibilities for the immunotherapy of rheumatoid arthritis.
    Breedveld FC; De Vries RR
    Clin Rheumatol; 1990 Jun; 9(2):171-5. PubMed ID: 2202541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.